Biography and Research Information
OverviewAI-generated summary
Meredith Verret's research focuses on the interpretation of cellular markers in the classification of various cancers. Verret was the lead author on a 2024 study published in an interobserver agreement study examining p16 and p53 in the classification of squamous cell carcinoma of the vulva. This work builds on previous research, including a 2023 multi-institutional retrospective review that investigated the spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population. Verret has co-authored four publications with Susanne K. Jeffus and three with Sarah Vestal, both from the University of Arkansas for Medical Sciences. Verret's scholarship metrics include an h-index of 2, with a total of four publications and eight citations.
Metrics
- h-index: 2
- Publications: 4
- Citations: 9
Selected Publications
-
Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study (2024)
-
In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology (2024)
-
The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review (2023)
-
The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review (2023)
Collaboration Network
Top Collaborators
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- The Spectrum of Malignant Diagnoses in Cerebrospinal Fluid Cytology from an Adult Population – A Multi-Institutional Retrospective Review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- The spectrum of malignant diagnoses in cerebrospinal fluid cytology from an adult population: a multi-institutional retrospective review
- In reply: Malignant tumor diagnoses in cerebrospinal fluid cytology
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
- Interpretation of p16 and p53 in the Classification of Squamous Cell Carcinoma of the Vulva—An Interobserver Agreement Study
Similar Researchers
Based on overlapping research topics